US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more. The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017. Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017. The global Oral Mucositis Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Oral Mucositis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Mucositis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: 3M Healthcare GSK Pfizer Colgate-Palmolive Norgine Biovitrum Valeant Pharmaceuticals EUSA Pharma Camurus Mission Pharmacal Clinigen Group Midatech Pharma Alliance Pharma AMAG Pharmaceuticals Segment by Regions North America Europe China Japan Segment by Type Mouthwash Pain Control Medication Other Segment by Application Chemotherapy Radiotherapy
Table of Contents Executive Summary 1 Oral Mucositis Drugs Market Overview 1.1 Product Overview and Scope of Oral Mucositis Drugs 1.2 Oral Mucositis Drugs Segment by Type 1.2.1 Global Oral Mucositis Drugs Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Mouthwash 1.2.3 Pain Control Medication 1.2.4 Other 1.3 Oral Mucositis Drugs Segment by Application 1.3.1 Oral Mucositis Drugs Consumption Comparison by Application (2014-2025) 1.3.2 Chemotherapy 1.3.3 Radiotherapy 1.4 Global Oral Mucositis Drugs Market by Region 1.4.1 Global Oral Mucositis Drugs Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Oral Mucositis Drugs Market Size 1.5.1 Global Oral Mucositis Drugs Revenue (2014-2025) 1.5.2 Global Oral Mucositis Drugs Production (2014-2025) 2 Global Oral Mucositis Drugs Market Competition by Manufacturers 2.1 Global Oral Mucositis Drugs Production Market Share by Manufacturers (2014-2019) 2.2 Global Oral Mucositis Drugs Revenue Share by Manufacturers (2014-2019) 2.3 Global Oral Mucositis Drugs Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Oral Mucositis Drugs Production Sites, Area Served, Product Types 2.5 Oral Mucositis Drugs Market Competitive Situation and Trends 2.5.1 Oral Mucositis Drugs Market Concentration Rate 2.5.2 Oral Mucositis Drugs Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Oral Mucositis Drugs Production Market Share by Regions 3.1 Global Oral Mucositis Drugs Production Market Share by Regions 3.2 Global Oral Mucositis Drugs Revenue Market Share by Regions (2014-2019) 3.3 Global Oral Mucositis Drugs Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Oral Mucositis Drugs Production 3.4.1 North America Oral Mucositis Drugs Production Growth Rate (2014-2019) 3.4.2 North America Oral Mucositis ... | read more...